February 2010 |
131 |
VOLUME 9 • ISSUE 2 |
Copyright © 2010 |
Original Article |
Journal of Drugs in Dermatology |
February 2010 |
131 |
VOLUME 9 • ISSUE 2 |
Copyright © 2010 |
Original Article |
Journal of Drugs in Dermatology |
A Randomized, Investigator-Blinded Trial to Assess the Antimicrobial Efficacy of a Benzoyl Peroxide 5%/Clindamycin Phosphate 1% Gel Compared With a Clindamycin Phosphate 1.2%/Tretinoin 0.025% Gel in the Topical Treatment of Acne Vulgaris
Abstract
Background: Combination products in which the individual components have different mechanisms of antimicrobial action have
been shown in many disease states to provide the most effective therapy.
Methods: This 16-week, two-center, investigator-blinded, randomized, parallel-group study evaluated the antimicrobial efficacy of
clindamycin phosphate 1%/benzoyl peroxide 5% gel (BPO/C) as compared to a clindamycin phosphate 1.2%/tretinoin 0.025% gel
(T/C) over 16 weeks in the treatment of moderate to moderately severe acne.
Results: While subjects in both arms experienced reductions in total Propionibacterium acnes (P. acnes) counts, the BPO/C arm
produced greater reductions throughout the study. Furthermore, overall reductions in the number of clindamycin-resistant and erythromycin-
resistant P. acnes occurred only in BPO/C treated subjects.
Conclusion: These data suggest that clindamycin phosphate 1%/benzoyl peroxide 5% gel reduces P. acnes counts and mitigates
the emergence of antimicrobial resistance.